Publication | Open Access
Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older
10
Citations
27
References
2022
Year
VaccinationVaccine SafetyVaccine DevelopmentHumoral Immune ResponseImmunologyHumoral ImmunityVaccine EfficacyMedicineVaccine ResearchViral ImmunityCovid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1